Cirata, the recovering active data replication supplier previously known as WANdisco, has pulled in fresh funding after announcing a strengthened Symphony OEM product supply deal with IBM.
Symphony is a data mobility and orchestration product, replicating active data as it appears in a source location to a remote target. IBM is branding it Cirata Symphony for IBM Big Replicate. Cirata has raised £5.1 million ($6.62 million) by placing 34,155,349 new ordinary shares with buyers at a price of £0.15 ($0.20) The buyers include the board chairman, directors, including CEO Stephen Kelly, and senior employees of Cirata as well as US citizens, and existing shareholders. A separate retail share offer raised £0.32 million $420K) through the issue of 2,155,622 new Ordinary Shares at the issue price of 15 pence per share.
Kelly said: "Cirata, today, is a transformed business - driven forward by an energized team, and pointed at a significant, growing market. We have rescued, rebuilt and recovered the business, to the point where in fy25 we delivered our first triple-digit sales growth year. Today, a significantly de-risked and restructured Cirata is operating at approximately less than 30 percent of its peak expense levels and we are proud to have placed a home-grown UK software firm on an increasingly clear, commercially-proven pathway to sustainable value creation.
Cirata said it received strong support from existing shareholders during the fund-raising process. This validates the actions taken by Kelly’s new management team in making the company more efficient, rebranding it and repositioning the products to take advantage of the need for real-time data in analytics and AI processing.
In April, Cirata reported the first positive cash flow quarter in its reporting history and the the highest fy2025 data integration bookings since 2017, with 77 percent revenue growth Y/Y. In November 2025, it announced a $6.7m, 3-year data integration software contract with IBM for a financial services customer, under IBM’s existing OEM sales agreement for the Big Replicate platform. That contract represented the largest contract with IBM in Cirata’s history.
Kelly said: “A dedicated team across every layer of our organization has worked hard to reset, restore and re-energize Cirata. From an under-capitalized position, the strategic capital injection … provides our team with a stronger foundation on which to drive new logo acquisition, accelerate pipeline conversion and keep scaling the next-generation Cirata Symphony product: the live data, zero-disruption solution we believe is designed for an Agentic future."
He thinks that, “By 2029, we believe some 70 percent of enterprises will have deployed Agentic AI infrastructure - and we believe our products deliver the continuous, governed, and always-on mobility of live data these use cases require.”
Completion of these fund-raising deals are conditional upon shareholders agreeing to them at Cirata’s annual general meeting on July 24. That would seem to be a foregone conclusion, and then we can forget about the disreputable WANdisco difficulties and look ahead.